Centrifugal Blood Pumps Market Size

Centrifugal Blood Pumps Market Size

Centrifugal Blood Pumps Market size was valued at around USD 95.1 million in 2023 and is estimated to grow at 5.3% CAGR from 2024 to 2032. Centrifugal blood pumps are mechanical devices used to assist or replace the heart's function in pumping blood throughout the body. They operate on the principle of centrifugal force, where blood is drawn into the pump and accelerated outward by a rotating impeller or rotor. This acceleration creates a pressure gradient that propels the blood into the circulatory system.

To get key market trends

  Download Free Sample

The rising prevalence of cardiovascular diseases (CVDs) is a significant catalyst for the market. With an aging population and lifestyle factors such as obesity, hypertension, and diabetes on the rise, the incidence of conditions like heart failure and coronary artery disease is also increasing. For instance, according to a 2023 study from the National Library of Medicine, around 6.7 million adults in the U.S. have heart failure (HF), a figure expected to grow to 8.5 million by 2030. The lifetime risk of developing HF has reached 24%, indicating that roughly one in four people will experience heart failure at some stage in their lives. Centrifugal blood pumps play a crucial role in managing severe cases of heart failure and complex cardiac procedures, thereby enhancing patient outcomes. This growing need for effective cardiac support solutions is driving market growth.

Moreover, increasing investment in cardiovascular research and development (R&D) is a major accelerator for the centrifugal blood pumps market. Funding from both public and private sectors fosters the advancement of innovative technologies and therapies for cardiovascular diseases. Research focuses on enhancing pump designs, materials, and integration with other cardiac systems, leading to more effective and safer devices. Collaborative efforts accelerate the translation of research into clinical practice, boosting the development of next-generation centrifugal blood pumps and driving market innovation and growth.